Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 6/20 | 1.00 |
| ▸ | NR1H3 | Q13133 | 6/20 | 1.00 |
| ▸ | RORC | P51449 | 5/20 | 1.00 |
| ▸ | OSBP2 | Q969R2 | 3/20 | 1.00 |
| ▸ | CRYAB | P02511 | 1/20 | 1.00 |
| ▸ | HMGCR | P04035 | 1/20 | 1.00 |
| ▸ | ITGB3 | P05106 | 1/20 | 1.00 |
| ▸ | ITGAV | P06756 | 1/20 | 1.00 |
| ▸ | SREBF2 | Q12772 | 1/20 | 1.00 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 1.00 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.91 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.91 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.91 |
| ▸ | USP2 | O75604 | 1/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.80 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.80 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.80 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.74 |
| ▸ | DHCR24 | Q15392 | 1/20 | 0.73 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6388323 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL15435130 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL3420850 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL25035613 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL177267 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL23563231 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL17049791 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL14420777 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL22559541 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB | |
| SCHEMBL20299556 | 1.00 | OSBP (1.00) | OSBPNR1H3RORCOSBP2CRYAB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2973 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090423-A1 | UNIVERSAL LNP COMPOSITIONS | PRIME MEDICINE, INC (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4706644-A1 | RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL | Mepsgen Co., Ltd. (KR) | 2026-03-11 | — | — | EP | claimed |
| US-20250345284-A1 | LIPID NANOPARTICLE (LNP) COMPOSITIONS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-11-13 | — | — | US | claimed |
| US-20250345358-A1 | HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS | MANDOS LLC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250297310-A1 | HEMATOPOIETIC LOSS OF Y CHROMOSOME LEADS TO CARDIAC FIBROSIS AND DYSFUNCTION AND IS ASSOCIATED WITH DEATH DUE TO HEART FAILURE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-09-25 | — | — | US | claimed |
| US-20250297321-A1 | METHOD FOR DETECTING METABOLIC REPROGRAMING OF CANCER TOWARDS FATTY ACIDS METABOLISM | INST NAT SANTE RECH MED (FR) | 2025-09-25 | — | — | US | claimed |
| EP-3911302-B1 | DRUG DELIVERY SYSTEMS CONTAINING OXIDIZED CHOLESTEROLS | GEORGIA TECH RES INST (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250249021-A1 | Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic Oligosaccharide | JPMORGAN CHASE BANK, N.A. | 2025-08-07 | — | — | US | claimed |
| US-20250213589-A1 | METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION | Maximus Health, Inc. (US) | 2025-07-03 | — | — | US | claimed |
| WO-2025137591-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR PROMOTING ZINC SOLUBILIZATION AND ZINC UPTAKE IN PLANTS | Tenfold Technologies, LLC (US) | 2025-06-26 | — | — | WO | claimed |
| WO-1991015213-A1 | SIDE-CHAIN HYDROXYLATED CHOLESTEROL DERIVATIVES, AGENTS FOR DISSOLUTION OF CHOLESTEROL GALLSTONES | THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) | 1991-10-17 | — | — | WO | claimed |
| WO-1991011452-A1 | PRODUCTION OF GLYCOSIDES, ESPECIALLY OF STEROIDAL GLYCOSIDES | 'HARRIER' GMBH GESELLSCHAFT FÜR DEN VERTRIEB MEDIZINISCHER UND TECHNISCHER GERÄTE (DE) | 1991-08-08 | — | — | WO | claimed |
| US-4961922-A | Complexes based on anthralin and a sterol, a process for obtaining them and their use in therapeutics and cosmetics | Centre International De Recherches Dermatolociques (FR) | 1990-10-09 | — | — | US | claimed |
| EP-0258434-A4 | COMPOSITION COMPRISING AN OXYGENATED CHOLESTEROL. | JAVITT NORMAN B (US) | 1989-11-07 | — | — | EP | claimed |
| EP-0258434-A1 | COMPOSITION COMPRISING AN OXYGENATED CHOLESTEROL | JAVITT, Norman B. (US) | 1988-03-09 | — | — | EP | claimed |
| WO-1987004346-A1 | COMPOSITION COMPRISING AN OXYGENATED CHOLESTEROL AND USE THEREOF FOR TOPICAL TREATMENT OF DISEASES | JAVITT NORMAN B | 1987-07-30 | — | — | WO | claimed |
| EP-0021235-A1 | Preparation of 25-hydroxycholesterol | DIAMOND SHAMROCK CORPORATION (US) | 1981-01-07 | — | — | EP | claimed |
| US-4183852-A | Process for preparing 25-hydroxycholesterol | KAISER EMIL T (US) | 1980-01-15 | — | — | US | claimed |
| US-4134904-A | Synthesis of steroids | KAISER EMIL T | 1979-01-16 | — | — | US | claimed |
| US-3959320-A | Process and compounds | THE UPJOHN COMPANY (US) | 1976-05-25 | — | — | US | claimed |